9 completed, 1 recruiting, 1 terminated, 1 withdrawn. 4 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 4 | 2 | Completed 2 |
Follow Povidone: new trials by email Literature Review of Povidone trials Research Report on Povidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses) Hydrocortisone, Dexamethasone, Povidone - Ocular Inflammation, Ocular Prostheses | Phase 3 | Recruiting | Agnes | 30 | 2023-05-12 | 2025-08-15 |
| Impact of a Newly Formulated Toothpaste in Tooth Staining Associated With Chlorhexidine Rinses Toothpaste with hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP), Toothpaste without hexametaphosphate, tripolyphosphate and polyvinylpyrrolidone (PVP) - Tooth Staining, Periodontitis | Not applicable | Completed | Universidad Complutense de Madrid | 70 | 2022-10-01 | 2024-05-09 |
| Vaginal Cleansing With Chlorhexidine Versus Iodine for Prevention of Endometritis Povidone-Iodine, Chlorhexidine Gluconate - Endometritis, Vaginal Cleansing | Not applicable | Completed | Federal Teaching Hospital Abakaliki | 239 | 2020-06-01 | 2025-05-01 |
| Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 Saline oral/nasal rinse, 0.5% Povidone/Iodine oral/nasal rinse, 0.12% Chlorhexidine oral/nasal rinse - COVID-19 | Phase 2 | Withdrawn | NYU Langone Health | 2020-04-09 | 2021-05-10 | |
| The Effect of Antibiotic Eye Drops on the Nasal Microbiome in Healthy Subjects Gentamicin Ophthalmic, Ciprofloxacin Ophthalmic, Povidone Ophthalmic - Nasal and Pharyngeal Microbiome | Phase 2 | Completed | Medical University of Vienna | 20 | 2019-08-12 | 2025-05-16 |
| Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery Cytoflavin® solution, Cytoflavin® enteric-coated tablet, Placebo solution - Cognitive Dysfunction | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 200 | 2017-06-02 | 2023-01-31 |
| Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye REMOGEN OMEGA, Povidone - Dry Eye Syndromes | Not applicable | Completed | TRB Chemedica AG | 81 | 2016-10-01 | 2018-08-15 |
| Comparison of Autologous Serum Versus Preservative Free Artificial Tear %40 diluted Autologous serum, Preservative free artificial tears(Tears naturale free, Refresh single dose eye drop) - Dry Eye | Phase 4 | Completed | Niğde State Hospital | 24 | 2015-10-01 | 2016-04-27 |
| Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection After Cesarean Section Clorhexidine, Povidone - Surgical Wound Infection | Not applicable | Completed | Saint Thomas Hospital, Panama | 800 | 2012-10-01 | 2013-05-17 |
| Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Azithromycin, Povidone - Blepharitis | Phase 2 | Completed | Laboratoires Thea | 93 | 2010-03-01 | 2014-11-04 |
| A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections povidone-iodine solution, chlorhexidine gluconate - Wound Infection | Phase 3 | Terminated | Memorial University of Newfoundland | 268 | 2007-12-01 | 2012-11-09 |
| Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers Povidone K25 eye drops (povidone) - Healthy | Phase 4 | Completed | Novartis | 30 | 2004-03-01 | 2011-11-17 |
Dry Eye Syndromes (2) · Blepharitis (1) · COVID-19 (1) · Cognitive Dysfunction (1) · Endometritis (1) · Erythema (1) · Fever (1) · Infections (1) · Leukocytosis (1) · Periodontitis (1) · Postoperative Cognitive Complications (1) · Sepsis (1) · Surgical Wound Infection (1) · Tooth Discoloration (1) · Vaginal Discharge (1)
Agnes (1) · Federal Teaching Hospital Abakaliki (1) · Laboratoires Thea (1) · Medical University of Vienna (1) · Memorial University of Newfoundland (1) · NYU Langone Health (1) · Niğde State Hospital (1) · Novartis (1) · POLYSAN Scientific & Technological Pharmaceutical Company (1) · Saint Thomas Hospital, Panama (1) · TRB Chemedica AG (1) · Universidad Complutense de Madrid (1)
France (2) · Germany (2) · Austria (1) · Canada (1) · Nigeria (1) · Panama (1) · Russia (1) · Spain (1) · Turkey (Türkiye) (1) · United States (1)
David Herrera, Prof. (1) · PD. Dr. G. Auffarth (1) · Paula Mallaley, MD (1) · Scott Rickert, MD (1) · Tatiana V Kharitonova, MD, PhD (1) · Thomas Kaercher, Dr. (1)
2009 (1)